• About us
• Contact

Advertisement

Organisation › Details

Owkin (Group)

Owkin is the first end-to-end TechBio company on a mission to understand complex biology and derive new multimodal biomarkers through AI. We identify precision therapeutics, de-risk and accelerate clinical trials and develop diagnostics using AI trained on world-class patient data through privacy-enhancing federated technologies. We merge wet lab experiments with advanced AI techniques to create a powerful feedback loop for accelerated discovery and innovation in oncology, cardiovascular, immunity and inflammation. Owkin also founded MOSAIC, the world’s largest spatial multi-omics atlas for cancer research. Owkin has raised over $300 million through investments from leading biopharma companies, including Sanofi and BMS, and venture funds like Fidelity, GV and Bpifrance, among others. *

 

	Start	2016-01-01 established
	Industry	artificial intelligence (AI) / machine learning (ML)
	Industry 2	Owkin Socrates
	Person	Clozel, Thomas (Owkin 202111 CEO + Co-Founder)
	Region	Paris
	Country	France
	Street	12 Rue Martel
	City	75010 New York, NY
		Address record changed: 2024-01-05
Basic data	Employees	n. a.
		* Document for »About Section«: Owkin. (3/21/24). "Press Release: Owkin Expands Collaboration with Sanofi Leveraging AI for Drug Positioning in immunology".
		Record changed: 2024-03-30

Advertisement

More documents for Owkin (Group)

• [1] Owkin. (3/21/24). "Press Release: Owkin Expands Collaboration with Sanofi Leveraging AI for Drug Positioning in immunology"....
• [2] Evotec SE. (1/4/24). "Press Release: Evotec and Owkin Enter an A.I.-powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I". Hamburg & Paris....
• [3] Owkin. (12/19/23). "Press Release: Owkin Enters Collaboration Agreement with MSD to Develop AI-powered Diagnostics for Cancer"....
• [4] Owkin. (11/21/23). "Press Release: Owkin Expands Reach of AI Diagnostic for Colorectal Cancer through Integration with Sectra"....
• [5] Owkin. (10/17/23). "Press Release: Servier Partners with Owkin with the Aim of Discovering and Developing AI-driven Precision Therapeutics"....
• [6] Owkin. (10/4/22). "Press Release: Owkin Appoints Sanofi’s Global Head of Partnering Alban de La Sablière as Chief Business Officer"....
• [7] Owkin. (9/13/22). "Press Release: Owkin and 12 Partners Launch $14 Million NIH Project to Allow Doctors to Spot Cancer, Depression and other Diseases from the Human Voice"....
• [8] Sanofi S.A.. (11/18/21). "Press Release: Sanofi Invests $180 Million Equity in Owkin’s Artificial Intelligence and Federated Learning to Advance Oncology Pipeline". Paris....
• [9] Owkin. (12/2/19). "Press Release: Owkin Teams up with NVIDIA and King's College London to Deliver AI to Hospitals While Protecting Patient Data With Federated Learning". Paris & New York....
• [10] Owkin. (1/16/18). "Press Release: Owkin Closes $11 Million Series A Financing Round". New York, NY....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.